China overtook Japan as the world’s second-biggest healthcare market in 2013, and with its annual healthcare spending forecast to reach nearly US$900bn by 2018, it will rapidly close the gap on the US, reports the Economist Intelligence Unit (EIU).
China overtook Japan as the world’s second-biggest healthcare market in 2013, and with its annual healthcare spending forecast to reach nearly US$900bn by 2018, it will rapidly close the gap on the US, reports the Economist Intelligence Unit (EIU).
EIU’s China Healthy Province Index (CHPI) provides a detailed healthcare profile of each of China’s 31 provinces,ranking provinces according to which are best placed in terms of resources and financing to meet current and anticipated healthcare demand. Beijing tops the CHPI, but one of the surprising outcomes was the strong performance of poorer provinces such as Qinghai and Gansu. Sparse populations in such regions ease pressure on local healthcare systems. Those that bottomed out include the rapidly developing central provinces of Henan and Anhui, densely populated regions where access to healthcare and funding is low despite booming local demand.
The EIU also reports how the Chinese government has been opening up the healthcare system to private sector investment, but warns that stresses in the system our mounting, as popular frustration over costs and access begins to “boil over”.
More information: http://www.eiu.com/chpi2014
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.